OpenLegislation

Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 (Text with EEA relevance) (repealed)

EU Regulation No 2032/2003 · Adopted 4 November 2003 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Regulation (EC) No 2032/2003

of 4 November 2003

on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000

(Text with EEA relevance) (repealed)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Repealed by Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance).

Contents

  1. 1Subject matter Repealed
  2. 2Definitions Repealed
  3. 3Existing Active Substances Repealed
  4. 4Non-inclusion Repealed
  5. 4aEssential use Repealed
  6. 4bExtension of deadline for placing on the market Repealed
  7. 5Review of notified existing active substances Repealed
  8. 6Preparation of the complete dossier Repealed
  9. 7Submission of the complete dossier Repealed
  10. 8Joining, replacing or withdrawal of participants Repealed
  11. 9Completeness check of dossiers Repealed
  12. 10Evaluation of dossiers by the Rapporteur Member State Repealed
  13. 11Commission procedures Repealed
  14. 12Article 12 Repealed
  15. 13Suspension of procedures Repealed
  16. 14Amendments to Regulation (EC) No 1896/2000 Repealed
  17. 15Entry into force Repealed
  18. Signature
  19. Annex IEXISTING ACTIVE SUBSTANCES Repealed
  20. Annex IIEXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMME Repealed
  21. Annex IIIEXISTING ACTIVE SUBSTANCES THAT HAVE BEEN IDENTIFIED BUT IN RESPECT OF WHICH NO NOTIFICATION HAS BEEN ACCEPTED OR NO MEMBER STATE HAS INDICATED AN INTEREST AND EXISTING ACTIVE SUBSTANCES THAT HAD BEEN NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH NO PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT Repealed
  22. Annex IV: REQUIREMENTS FOR THE COMPLETE DOSSIER AND THE SUMMARY DOSSIER Repealed
  23. (a)Division (a) Repealed
  24. (b)The summary dossier must include the following: Repealed
  25. (c)Division (c) Repealed
  26. (d)Division (d) Repealed
  27. Annex V: TIME PERIODS AND RAPPORTEUR MEMBER STATES FOR THE SUBMISSION OF COMPLETE DOSSIERS FOR EXISTING ACTIVE SUBSTANCES INCLUDED IN THE REVIEW PROGRAMME Repealed
  28. APart A Repealed
  29. BPart B Repealed
  30. CPart C Repealed
  31. DPart D Repealed
  32. Annex VI: COMPETENT AUTHORITIES, AS REFERRED TO IN ARTICLE 5(4) AS OF 1 MARCH 2005 Repealed
  33. BELGIUM Repealed
  34. CZECH REPUBLIC Repealed
  35. DENMARK Repealed
  36. GERMANY Repealed
  37. ESTONIA Repealed
  38. GREECE Repealed
  39. SPAIN Repealed
  40. FRANCE Repealed
  41. IRELAND Repealed
  42. ITALY Repealed
  43. CYPRUS Repealed
  44. LATVIA Repealed
  45. LITUANIA Repealed
  46. LUXEMBOURG Repealed
  47. HUNGARY Repealed
  48. MALTA Repealed
  49. NETHERLANDS Repealed
  50. AUSTRIA Repealed
  51. POLAND Repealed
  52. PORTUGAL Repealed
  53. SLOVENIA Repealed
  54. SLOVAKIA Repealed
  55. FINLAND Repealed
  56. SWEDEN Repealed
  57. UNITED KINGDOM Repealed
  58. ICELAND Repealed
  59. NORWAY Repealed
  60. Annex VIIEXISTING ACTIVE SUBSTANCES THAT WERE NOT IDENTIFIED BY 28 MARCH 2002 BUT MAY REMAIN ON THE MARKET UNTIL 1 SEPTEMBER 2006 Repealed
  61. Annex VIIIEXISTING ACTIVE SUBSTANCES THAT WERE NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH ANOTHER PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT Repealed

1Subject matterF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2DefinitionsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Existing Active SubstancesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Non-inclusionF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4aEssential useF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4bExtension of deadline for placing on the marketF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Review of notified existing active substancesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Preparation of the complete dossierF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7Submission of the complete dossierF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Joining, replacing or withdrawal of participantsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9Completeness check of dossiersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10Evaluation of dossiers by the Rapporteur Member StateF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11Commission proceduresF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13Suspension of proceduresF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14Amendments to Regulation (EC) No 1896/2000F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

15Entry into forceF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IEXISTING ACTIVE SUBSTANCESF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IIEXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMMEF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IIIEXISTING ACTIVE SUBSTANCES THAT HAVE BEEN IDENTIFIED BUT IN RESPECT OF WHICH NO NOTIFICATION HAS BEEN ACCEPTED OR NO MEMBER STATE HAS INDICATED AN INTEREST AND EXISTING ACTIVE SUBSTANCES THAT HAD BEEN NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH NO PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANTF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(a)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(b)The summary dossier must include the following:F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(c)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(d)F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BELGIUM

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CZECH REPUBLIC

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DENMARK

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GERMANY

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ESTONIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GREECE

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPAIN

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FRANCE

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IRELAND

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITALY

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

CYPRUS

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LATVIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LITUANIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUXEMBOURG

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

HUNGARY

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

MALTA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NETHERLANDS

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AUSTRIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

POLAND

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PORTUGAL

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SLOVENIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SLOVAKIA

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FINLAND

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SWEDEN

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UNITED KINGDOM

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ICELAND

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NORWAY

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex VIIEXISTING ACTIVE SUBSTANCES THAT WERE NOT IDENTIFIED BY 28 MARCH 2002 BUT MAY REMAIN ON THE MARKET UNTIL 1 SEPTEMBER 2006F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex VIIIEXISTING ACTIVE SUBSTANCES THAT WERE NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH ANOTHER PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANTF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .